$89.8M in CY2024 Part D spend704K claims · 225K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Lubiprostone used for?
Lubiprostone is a chloride channel activator indicated for the treatment of: chronic idiopathic constipation (CIC) in adults. ( 1.1 ) opioid-induced constipation (OIC) in adult patients with chroni....
Is there a generic for Lubiprostone?
Yes. 10 ANDAs filed at FDA, 5 generic manufacturers currently shipping.
How much does my plan pay for Lubiprostone?
Across 329 Part D plans, Lubiprostone averages $0.717/unit (NADAC). Lowest available: $0.698/unit. Highest in distribution: $0.745/unit.
Is Lubiprostone on the FDA shortage list?
No. Lubiprostone is not currently on the FDA Drug Shortage Database.
6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.